AVBP Cash-Secured Put Strategy

AVBP (ArriVent BioPharma, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. The company’s lead development candidate is firmonertinib, a tyrosine kinase inhibitor that is being evaluated in multiple clinical trials across a range of epidermal growth factor receptor mutations (EGFRm) in non-small cell lung cancer (NSCLC), including a Phase 3 clinical trial for treatment of patients with advanced or metastatic EGFRm NSCLC with exon 20 insertion mutations, as well as Phase 1b clinical trials to treat NSCLC patients with activating EGFRm, including P-loop and-alpha-c-helix compressing (PACC) mutations, and classical EGFRm NSCLC patients. It is also developing ARR-217, an antibody drug conjugate (ADC) for the treatment of gastrointestinal cancers; and ARR-002, ARR-421, and ARR-173 for solid tumors. The company has strategic collaborations with Aarvik Therapeutics Inc., Shanghai Allist Pharmaceuticals Co., Ltd., Beijing InnoCare Pharma Tech Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd., and Lepu Biopharma Co. Ltd. ArriVent BioPharma, Inc. was incorporated in 2021 and is based in Newtown Square, Pennsylvania.

AVBP (ArriVent BioPharma, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.58B, a beta of 1.42 versus the broader market, a 52-week range of 16.1-35.83, average daily share volume of 527K, a public-listing history dating back to 2024, approximately 77 full-time employees. These structural characteristics shape how AVBP stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.42 indicates AVBP has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a cash-secured put on AVBP?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current AVBP snapshot

As of June 30, 2026, spot at $34.70, ATM IV 157.80%, IV rank 35.33%, expected move 45.24%. The cash-secured put on AVBP below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this cash-secured put structure on AVBP specifically: AVBP IV at 157.80% is mid-range versus its 1-year history, so the credit collected on a AVBP cash-secured put sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 45.24% (roughly $15.70 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AVBP expiries trade a higher absolute premium for lower per-day decay. Position sizing on AVBP should anchor to the underlying notional of $34.70 per share and to the trader's directional view on AVBP stock.

AVBP cash-secured put setup

The AVBP cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AVBP near $34.70, the first option leg uses a $32.97 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AVBP chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AVBP shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$32.97N/A

AVBP cash-secured put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

AVBP cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on AVBP. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on AVBP

Cash-secured puts on AVBP earn premium while a trader waits to acquire AVBP stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning AVBP.

AVBP thesis for this cash-secured put

The market-implied 1-standard-deviation range for AVBP extends from approximately $19.00 on the downside to $50.40 on the upside. A AVBP cash-secured put lets a trader earn premium while waiting to acquire AVBP at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current AVBP IV rank near 35.33% is mid-range against its 1-year distribution, so the IV signal is neutral; the cash-secured put thesis on AVBP should anchor more to the directional view and the expected-move geometry. As a Healthcare name, AVBP options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AVBP-specific events.

AVBP cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AVBP positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AVBP alongside the broader basket even when AVBP-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on AVBP carry tail risk when realized volatility exceeds the implied move; review historical AVBP earnings reactions and macro stress periods before sizing. Always rebuild the position from current AVBP chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on AVBP?
A cash-secured put on AVBP is the cash-secured put strategy applied to AVBP (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With AVBP stock trading near $34.70, the strikes shown on this page are snapped to the nearest listed AVBP chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are AVBP cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the AVBP cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 157.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a AVBP cash-secured put?
The breakeven for the AVBP cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AVBP market-implied 1-standard-deviation expected move is approximately 45.24%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on AVBP?
Cash-secured puts on AVBP earn premium while a trader waits to acquire AVBP stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning AVBP.
How does current AVBP implied volatility affect this cash-secured put?
AVBP ATM IV is at 157.80% with IV rank near 35.33%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related AVBP analysis